{
    "id": 5481,
    "fullName": "FGFR4 Y367C",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "FGFR4 Y367C lies within the extracellular domain of the Fgfr4 protein (UniProt.org). Y367C results in Fgfr4 dimerization and constitutive activation of downstream signaling (PMID: 19946327).",
            "references": [
                {
                    "id": 2589,
                    "pubMedId": 19946327,
                    "title": "The FGFR4 Y367C mutant is a dominant oncogene in MDA-MB453 breast cancer cells.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19946327"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 2264,
        "geneSymbol": "FGFR4",
        "terms": [
            "FGFR4",
            "CD334",
            "JTK2",
            "TKF"
        ]
    },
    "variant": "Y367C",
    "createDate": "04/28/2015",
    "updateDate": "04/28/2015",
    "referenceTranscriptCoordinates": {
        "id": 164692,
        "transcript": "NM_213647",
        "gDna": "chr5:g.177093180A>G",
        "cDna": "c.1100A>G",
        "protein": "p.Y367C",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 10804,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, BLU9931 inhibited Fgfr4 activation and downstream signaling in breast cancer cells harboring FGFR4 Y367C in culture (PMID: 25776529).",
            "molecularProfile": {
                "id": 5293,
                "profileName": "FGFR4 Y367C"
            },
            "therapy": {
                "id": 2509,
                "therapyName": "BLU9931",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2415,
                    "pubMedId": 25776529,
                    "title": "First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25776529"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 9770,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a breast cancer cell line xenograft model harboring FGFR4 Y367C demonstrated sensitivity to ASP5878 in culture, resulting in suppression of both Fgfr4 phosphorylation and Erk phosphorylation (PMID: 27837028).",
            "molecularProfile": {
                "id": 5293,
                "profileName": "FGFR4 Y367C"
            },
            "therapy": {
                "id": 3584,
                "therapyName": "ASP5878",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 7585,
                    "pubMedId": 27837028,
                    "title": "ASP5878, a Novel Inhibitor of FGFR1, 2, 3, and 4, Inhibits the Growth of FGF19-Expressing Hepatocellular Carcinoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27837028"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 11180,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Balversa (erdafitinib) inhibited proliferation of a breast cancer cell line harboring FGFR4 Y367C in culture, and inhibited tumor growth in xenograft models (PMID: 28341788).",
            "molecularProfile": {
                "id": 5293,
                "profileName": "FGFR4 Y367C"
            },
            "therapy": {
                "id": 1028,
                "therapyName": "Erdafitinib",
                "synonyms": null
            },
            "indication": {
                "id": 1612,
                "name": "breast cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 9140,
                    "pubMedId": 28341788,
                    "title": "Discovery and Pharmacological Characterization of JNJ-42756493 (Erdafitinib), a Functionally Selective Small-Molecule FGFR Family Inhibitor.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28341788"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 5293,
            "profileName": "FGFR4 Y367C",
            "profileTreatmentApproaches": [
                {
                    "id": 9750,
                    "name": "FGFR4 Inhibitor",
                    "profileName": "FGFR4 Y367C"
                },
                {
                    "id": 9752,
                    "name": "STAT3 Inhibitor",
                    "profileName": "FGFR4 Y367C"
                },
                {
                    "id": 9751,
                    "name": "FGFR Inhibitor (Pan)",
                    "profileName": "FGFR4 Y367C"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 164693,
            "transcript": "NM_002011",
            "gDna": "chr5:g.177093180A>G",
            "cDna": "c.1100A>G",
            "protein": "p.Y367C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 164694,
            "transcript": "XM_005265838",
            "gDna": "chr5:g.177093180A>G",
            "cDna": "c.1100A>G",
            "protein": "p.Y367C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 164692,
            "transcript": "NM_213647",
            "gDna": "chr5:g.177093180A>G",
            "cDna": "c.1100A>G",
            "protein": "p.Y367C",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}